46 related articles for article (PubMed ID: 31030032)
21. Obesity and risk for venous thromboembolism from contemporary therapy for pediatric acute lymphoblastic leukemia.
Prasca S; Carmona R; Ji L; Ko RH; Bhojwani D; Rawlins YA; Mittelman SD; Young G; Orgel E
Thromb Res; 2018 May; 165():44-50. PubMed ID: 29567586
[TBL] [Abstract][Full Text] [Related]
22. Venous thromboembolism following L-asparaginase treatment for lymphoid malignancies in Korea.
Lee JH; Lee J; Yhim HY; Oh D; Bang SM
J Thromb Haemost; 2017 Apr; 15(4):655-661. PubMed ID: 28150907
[TBL] [Abstract][Full Text] [Related]
23. Incidence and Risk Factors of Venous Thromboembolism in Childhood Acute Lymphoblastic Leukaemia - a Population-Based Analysis of the Austrian Berlin-Frankfurt-Münster (BFM) Study Group.
Gidl A; Füreder A; Benesch M; Dworzak M; Engstler G; Jones N; Kropshofer G; Pötschger U; Poyer F; Tamesberger M; Witt V; Mann G; Attarbaschi A;
Pediatr Hematol Oncol; 2023 Mar; 40(2):181-191. PubMed ID: 35848787
[TBL] [Abstract][Full Text] [Related]
24. TropicALL study: Thromboprophylaxis in Children treated for Acute Lymphoblastic Leukemia with Low-molecular-weight heparin: a multicenter randomized controlled trial.
Klaassen ILM; Lauw MN; van de Wetering MD; Biemond BJ; Middeldorp S; Abbink FCH; Bierings M; Te Loo DMMW; Pieters R; van der Sluis IM; Tissing WJE; Michel Zwaan C; Heleen van Ommen C
BMC Pediatr; 2017 May; 17(1):122. PubMed ID: 28486976
[TBL] [Abstract][Full Text] [Related]
25. Venous thromboembolism incidence and risk factors in adults with acute lymphoblastic leukemia treated with and without pegylated E. coli asparaginase-containing regimens.
Kashanian SM; Holtzman NG; Patzke CL; Cornu J; Duffy A; Koka M; Niyongere S; Duong VH; Baer MR; Apata J; Kamangar F; Emadi A
Cancer Chemother Pharmacol; 2021 Jun; 87(6):817-826. PubMed ID: 33677674
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for symptomatic venous thromboembolism during therapy for childhood acute lymphoblastic leukemia.
Mateos MK; Trahair TN; Mayoh C; Barbaro PM; Sutton R; Revesz T; Barbaric D; Giles JE; Alvaro F; Mechinaud F; Catchpoole D; Kotecha RS; Dalla-Pozza L; Quinn MCJ; MacGregor S; Chenevix-Trench G; Marshall GM
Thromb Res; 2019 Jun; 178():132-138. PubMed ID: 31030032
[TBL] [Abstract][Full Text] [Related]
27. L-asparaginase and venous thromboembolism in acute lymphocytic leukemia.
Goyal G; Bhatt VR
Future Oncol; 2015; 11(17):2459-70. PubMed ID: 26274336
[TBL] [Abstract][Full Text] [Related]
28. Thrombosis in childhood acute lymphoblastic leukaemia: epidemiology, aetiology, diagnosis, prevention and treatment.
Nowak-Göttl U; Kenet G; Mitchell LG
Best Pract Res Clin Haematol; 2009 Mar; 22(1):103-14. PubMed ID: 19285277
[TBL] [Abstract][Full Text] [Related]
29. Venous thromboembolism in cancer patients.
Deng A; Galanis T; Graham MG
Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
[TBL] [Abstract][Full Text] [Related]
30. Epidemiology of venous thrombosis in children with cancer.
Piovesan D; Attard C; Monagle P; Ignjatovic V
Thromb Haemost; 2014 Jun; 111(6):1015-21. PubMed ID: 24522152
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for venous thromboembolism in children.
Gerotziafas GT
Int Angiol; 2004 Sep; 23(3):195-205. PubMed ID: 15765033
[TBL] [Abstract][Full Text] [Related]
32. Venous thromboembolism prophylaxis in the pediatric trauma population.
Thompson AJ; McSwain SD; Webb SA; Stroud MA; Streck CJ
J Pediatr Surg; 2013 Jun; 48(6):1413-21. PubMed ID: 23845640
[TBL] [Abstract][Full Text] [Related]
33. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.
Schoot RA; Kremer LC; van de Wetering MD; van Ommen CH
Cochrane Database Syst Rev; 2013 Sep; (9):CD009160. PubMed ID: 24026801
[TBL] [Abstract][Full Text] [Related]
34. Symptomatic venous thromboembolism following circular frame treatment for tibial fractures.
Vollans S; Chaturvedi A; Sivasankaran K; Madhu T; Hadland Y; Allgar V; Sharma HK
Injury; 2015; 46(6):1108-11. PubMed ID: 25910819
[TBL] [Abstract][Full Text] [Related]
35. Duration of anticoagulant therapy in pediatric venous thromboembolism: Current approaches and updates from randomized controlled trials.
Tarango C; Schulman S; Betensky M; Goldenberg NA
Expert Rev Hematol; 2018 Jan; 11(1):37-44. PubMed ID: 29183221
[TBL] [Abstract][Full Text] [Related]
36. Management of thrombotic complications in acute lymphoblastic leukemia.
Zia AN; Chitlur M
Indian J Pediatr; 2013 Oct; 80(10):853-62. PubMed ID: 23912824
[TBL] [Abstract][Full Text] [Related]
37. Risk assessment of venous thromboembolism in hematological cancer patients: a review.
Chan TS; Hwang YY; Tse E
Expert Rev Hematol; 2020 May; 13(5):471-480. PubMed ID: 32249620
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
